$BNZI SETUP IS GETTING DANGEROUS (FOR SHORTS) 🍋 BNZI sitting on key support $0.90–$0.97 after a long downtrend + tightening wedge. 📉 But Zoom Out… • $2.00 in January • $4.00 in October This name can move FAST when momentum hits. Key levels: ➡️ Pivot: $1.09 ➡️ Breakout: $1.30 (trendline) ➡️ Targets: $1.59 - $1.97 - $2.29+ ➡️ Macro upside: $3–$4 range 📅 Q4 earnings = catalyst Strong AI growth + 80% margins + Zacks BUY upgrade = narrative + chart aligning. Hold support = reversal setup. Break $1.30 = momentum trigger. 👀 Communicated - Disclaimefh.bio/jcoopGQ1m

🚨 DRONE WARFARE HAS ARRIVED AND $ZENA COULD BE ONE OF THE BIGGEST WINNERS 🚨 The battlefield is changing FAST… and if you’re not watching the drone space, you’re already behind. As global tensions rise, especially with the Iran conflict reshaping modern warfare, one thing is clear: Low-cost drones are dominating high-cost defense systems 🔥 Here’s why this is getting serious attention: ▫️ Drone-vs-Drone Warfare: ZENA is building autonomous interceptor systems designed to STOP hostile drones mid-air ▫️ Game-Changing Cost Advantage: Interceptor P-1 targeting < $5,000 per unit vs. missiles costing 10–100x more ▫️ AI + Autonomous Ecosystem: Not just hardware… full-stack platform (AI, SaaS, analytics, DaaS) ▫️ 20+ Acquisitions fueling rapid expansion and scalability ▫️ Growing U.S. Defense Engagement + global interest (NATO, GCC, allied forces) 💡 THE BIG PICTURE: Modern warfare is shifting toward scalable, AI-driven, low-cost solutions and ZENA is positioning itself right at that intersection. If drones are the future of warfare… then counter-drone systems are the gold rush. ⚡ With a prototype underway and catalysts ahead (development updates, defense contracts, pilots)… this is one to keep firmly on your radar. Communicated - Disclaimfh.bio/jcoopGQ1m

🚨 $ABX MADE A POWER MOVE IN WEALTH MANAGEMENT 🚨 Abacus Global Management is leveling up: ▪️ $53M strategic stake in Manning & Napier ▪️ Instant access to $18B AUM + 3,400 clients ▪️ 10,000 monthly leads fueling growth engine ▪️ Strategic alliance unlocking distribution + new product innovation (LifeARC data) This isn’t just an investment… it’s a scalable pipeline + revenue expansion machine. With closing expected in Q2 2026, ABX is positioning itself at the center of data-driven wealth + insurance convergence. Communicated- Disclaimerbit.ly/4rLMZtYOL

$GANX EARLY CLINICAL SIGNALS TURNING HEADS Gain Therapeutics just delivered strong Phase 1b data at AD/PD 2026: ▫️ CSF GluSph ↓ after 90 days ▫️ DDC ↓ in high-GluSph patients ▫️ MDS-UPDRS stable through Day 150 ▫️ 16/19 patients entered extension ▫️ New pipeline candidate (GT-04686) advancing Wall Street also sees serious upside potential as clinical momentum builds: ▪️ HC Wainwright: $8 PT ▪️ BTIG: $8 PT ▪️ Scotiabank: $12 PT ▪️ Roth Capital: $6 PT 🔥 Real biomarker + clinical signals with a 9-month extension underway into Sept 2026 + a consensus avg. price target of $7.5–$8. Do you think GANX is still flying under the radar? 🤔 Communicated - Disclaimerchartingdaily.com/structural-hea…NN

$GIFT TURNING THE CORNER… ARE YOU WATCHING? Giftify just dropped strong FY2025 numbers: ▫️ Billings +27% to $154.7M ▫️ Profit +18% with margins expanding ▫️ Expenses down 18% ▫️ Net loss shrinking fast ▫️ EBITDA nearly breakeven This is clean execution: growth + improving efficiency + clear path to profitability 💡 Early-stage leader forming. If they flip profitable… does GIFT start getting re-rated fast? Communicated - Disclaimer:chartingdaily.com/retail-rewardsQ

🚨 $AIRE RECENTLY DROPPED A MONSTER GROWTH REPORT reAlpha is proving it’s not just another proptech story… it’s a full-blown AI-powered real estate ecosystem in hyper-growth mode 📈 FY2025 HIGHLIGHTS: • Revenue: $4.5M (+376% YoY) • Gross Profit: $2.5M • Transactions: $116.1M (+203%) • Cash: $7.8M (+149%) • Raised: $25.5M to fuel expansion • Prevu acquisition. Now operating in 12 states + D.C. This is what early-stage scaling looks like: aggressive growth, expanding footprint, and heavy investment into AI + brokerage infrastructure. ⚠️ The setup is clear: AI + real estate + expanding brokerage = massive TAM + recurring revenue potential Don’t wait until the crowd catches on. Start watching AIRE NOW before momentum hits. Communicated - Disclaimerfh.bio/jcoop1m

NASA DOUBLES DOWN ON VOYAGER $VOYG Voyager Technologies just secured a multi-million-dollar follow-on contract with NASA under the ELVIS-3 program, continuing its role supporting NASA’s Launch Services Program at Kennedy Space Center. Bullish Highlights: ▫️ Multi-million-dollar NASA contract extension ▫️ Key role in launch vehicle integration & mission support ▫️ Supporting NASA robotic science & exploration missions ▫️ Strong positioning in the booming space & defense sector Government validation + recurring mission-critical work. 👀 Space infrastructure is heating up, keep a close eye on VOYG. Disclaimer:disclaimer.jcoopsolutions.com5